Patterns of hormone secretion throughout pregnancy in the one-humped camel (Camelus dromedarius).
Peripheral serum samples were collected from 8 pregnant dromedary camels and hormone secretion patterns were examined at specific time intervals. Mean serum progesterone concentrations began to rise 3-4 days after ovulation and remained reasonably constant at 3-5 ng mL-1 for the first 90-100 days of gestation. Concentrations then showed a definite fall, but thereafter remained constant again at 2-4 ng mL-1 throughout the rest of pregnancy. In contrast, serum oestrogen concentrations showed pronounced fluctuations during the first 100 days of gestation. Mean oestradiol-17 beta concentrations increased at around Day 50 to about 100 pg mL-1 and then remained relatively constant from Day 90 to Day 300. Mean oestrone sulfate concentrations, however, showed two definite peaks in early gestation, each reaching about 10 ng mL-1, with the first peak occurring around Day 25 and the second peak around Day 75. Oestrogen production then remained fairly constant until around Day 300, after which concentrations of both oestrone sulfate and free oestradiol-17 beta rose steeply over the next 80 days to reach mean peak values of 46 ng ML-1 and 518.7 pg mL-1, respectively, at the time of parturition. Concentrations of 13,14 dihydro-15-keto prostaglandin F2 alpha (PGFM) remained low and reasonably steady at 100-200 pg mL-1 during the first 320 days of pregnancy; thereafter, PGFM concentrations rose steeply over the next 50 days, before an explosive further increase to a peak of 1900 +/- 141 pg mL-1 mean +/- sem on the day of calving. These results suggest that, as in the cow, a major change in steroid synthetic capability and/or enzyme content of the placenta may occur at around 80% (Day 300) of gestation in the pregnant camel.
Skidmore
J A
JA
Camel Reproduction Laboratory, Nakhlee, Dubai, UAE.
Billah
M
M
Allen
W R
WR
D000818:Animals; D002162:Camelus / Q000097:blood / Q000378:metabolism*; D015237:Dinoprost / Q000031:analogs & derivatives* / Q000097:blood / Q000378:metabolism; D004797:Enzyme-Linked Immunosorbent Assay / Q000662:veterinary; D004958:Estradiol / Q000097:blood / Q000378:metabolism*; D004966:Estrogens, Conjugated (USP) / Q000097:blood / Q000378:metabolism*; D004970:Estrone / Q000031:analogs & derivatives* / Q000097:blood / Q000378:metabolism; D005260:Female; D011247:Pregnancy; D011270:Pregnancy, Animal / Q000097:blood / Q000378:metabolism*; D011374:Progesterone / Q000097:blood / Q000378:metabolism*; D011863:Radioimmunoassay / Q000662:veterinary
D004966:Estrogens, Conjugated (USP); C008228:15-keto-13,14-dihydroprostaglandin F2alpha; D004970:Estrone; D011374:Progesterone; D004958:Estradiol; D015237:Dinoprost; C017296:estrone sulfate